Erratum: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management (Cancer (2004) 100 (228-237))
Publication
, Journal Article
Crawford, J; Dale, DC; Lyman, GH
Published in: Cancer
May 1, 2004
Duke Scholars
Published In
Cancer
DOI
ISSN
0008-543X
Publication Date
May 1, 2004
Volume
100
Issue
9
Start / End Page
1993 / 1994
Related Subject Headings
- Oncology & Carcinogenesis
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Crawford, J., Dale, D. C., & Lyman, G. H. (2004). Erratum: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management (Cancer (2004) 100 (228-237)). Cancer, 100(9), 1993–1994. https://doi.org/10.1002/cncr.20218
Crawford, J., D. C. Dale, and G. H. Lyman. “Erratum: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management (Cancer (2004) 100 (228-237)).” Cancer 100, no. 9 (May 1, 2004): 1993–94. https://doi.org/10.1002/cncr.20218.
Crawford J, Dale DC, Lyman GH. Erratum: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management (Cancer (2004) 100 (228-237)). Cancer. 2004 May 1;100(9):1993–4.
Crawford, J., et al. “Erratum: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management (Cancer (2004) 100 (228-237)).” Cancer, vol. 100, no. 9, May 2004, pp. 1993–94. Scopus, doi:10.1002/cncr.20218.
Crawford J, Dale DC, Lyman GH. Erratum: Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management (Cancer (2004) 100 (228-237)). Cancer. 2004 May 1;100(9):1993–1994.
Published In
Cancer
DOI
ISSN
0008-543X
Publication Date
May 1, 2004
Volume
100
Issue
9
Start / End Page
1993 / 1994
Related Subject Headings
- Oncology & Carcinogenesis
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis